|
| 37976384 | LRH-1 agonist DLPC through STAT6 promotes macrophage polarization and prevents parenteral nutrition-associated cholestasis in mice. | Hepatology | 2024 |
| 36131538 | Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy. | Hepatology | 2023 |
| 37902507 | Sarcopenia is associated with osteopenia and impaired quality of life in children with genetic intrahepatic cholestatic liver disease. | Hepatol Commun | 2023 |
| 38055647 | Neonatal cholestasis in children with Alpha-1-AT deficiency is a risk for earlier severe liver disease with male predominance. | Hepatol Commun | 2023 |
| 37647292 | Expression of circadian regulatory genes is dysregulated by increased cytokine production in mice subjected to concomitant intestinal injury and parenteral nutrition. | PLoS One | 2023 |
| 37456676 | Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis. | JHEP Rep | 2023 |
| 37184518 | Clinical spectrum and genetic causes of mitochondrial hepatopathy phenotype in children. | Hepatol Commun | 2023 |
| 37278241 | Predictors of 6-year event-free survival in Alagille syndrome patients treated with maralixibat, an ileal bile acid transporter inhibitor. | Hepatology | 2023 |
| 37173326 | Pharmacologic inhibition of HNF4α prevents parenteral nutrition associated cholestasis in mice. | Sci Rep | 2023 |
| 37468479 | Publisher Correction: Pharmacologic inhibition of HNF4α prevents parenteral nutrition associated cholestasis in mice. | Sci Rep | 2023 |
| 37471052 | Cytomegalovirus in biliary atresia is associated with increased pretransplant death, but not decreased native liver survival. | Hepatol Commun | 2023 |
| 36441040 | Real-World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients. | Chest | 2023 |
| 36848082 | Stat3 role in the protective effect of FXR Agonist in parenteral nutrition-associated cholestasis. | Hepatol Commun | 2023 |
| 36633484 | Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury. | Hepatol Commun | 2023 |
| 36069569 | Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease. | Hepatology | 2023 |
| 36069569 | Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease. | Hepatology | 2023 |
| 34387888 | Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition-associated cholestasis in mice. | Hepatology | 2022 |
| 35506349 | Use of funded multicenter prospective longitudinal databases to inform clinical trials in rare diseases-Examination of cholestatic liver disease in Alagille syndrome. | Hepatol Commun | 2022 |
| 35672955 | Impact of long-term administration of maralixibat on children with cholestasis secondary to Alagille syndrome. | Hepatol Commun | 2022 |
| 36687469 | Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency. | JHEP Rep | 2022 |
| 35868689 | Fat Soluble Vitamin Assessment and Supplementation in Cholestasis. | Clin Liver Dis | 2022 |
| 36069338 | The discriminatory ability of FibroScan liver stiffness measurement, controlled attenuation parameter, and FibroScan-aspartate aminotransferase to predict severity of liver disease in children. | Hepatol Commun | 2022 |
| 35897136 | Macronutrient and Micronutrient Intake in Adolescents With Non-alcoholic Fatty Liver Disease: The Association With Disease Severity. | J Pediatr Gastroenterol Nutr | 2022 |
| 36378690 | The autophagic protein p62 is a target of reactive aldehydes in human and murine cholestatic liver disease. | PLoS One | 2022 |
| 35043117 | Real World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients. | medRxiv | 2022 |
| 35271743 | Risk of variceal hemorrhage and pretransplant mortality in children with biliary atresia. | Hepatology | 2022 |
| 35207217 | Incidence, Impact and Treatment of Ongoing CMV Infection in Patients with Biliary Atresia in Four European Centres. | J Clin Med | 2022 |
| 34669243 | Malnutrition in Biliary Atresia: Assessment, Management, and Outcomes. | Liver Transpl | 2022 |
| 34664730 | Interrupting tumor necrosis factor-alpha signaling prevents parenteral nutrition-associated cholestasis in mice. | JPEN J Parenter Enteral Nutr | 2022 |
| 34694263 | Neurodevelopmental Outcomes in Children With Inherited Liver Disease and Native Liver. | J Pediatr Gastroenterol Nutr | 2022 |
| 34310436 | Presentation and Outcomes of Infants With Idiopathic Cholestasis: A Multicenter Prospective Study. | J Pediatr Gastroenterol Nutr | 2021 |
| 33720099 | Use of a Comprehensive 66-Gene Cholestasis Sequencing Panel in 2171 Cholestatic Infants, Children, and Young Adults. | J Pediatr Gastroenterol Nutr | 2021 |
| 33666275 | Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency. | Hepatology | 2021 |
| 34850148 | Neonatal Cholestasis: Updates on Diagnostics, Therapeutics, and Prevention. | Neoreviews | 2021 |
| 34527288 | Fostering innovation at Academic Medical Centers: The Case of University of Colorado Anschutz Medical Campus. | J Clin Transl Sci | 2021 |
| 34774795 | miR-199a-5p inhibits the expression of ABCB11 in obstructive cholestasis. | J Biol Chem | 2021 |
| 34310734 | NF-κB Regulation of LRH-1 and ABCG5/8 Potentiates Phytosterol Role in the Pathogenesis of Parenteral Nutrition-Associated Cholestasis. | Hepatology | 2021 |
| 31503218 | Neurodevelopmental Outcomes in Preschool and School Aged Children With Biliary Atresia and Their Native Liver. | J Pediatr Gastroenterol Nutr | 2020 |
| 32003009 | New Insights Into Intestinal Failure-Associated Liver Disease in Children. | Hepatology | 2020 |
| 33313463 | Outcomes of Childhood Cholestasis in Alagille Syndrome: Results of a Multicenter Observational Study. | Hepatol Commun | 2020 |
| 33163838 | Nonfasted Liver Stiffness Correlates with Liver Disease Parameters and Portal Hypertension in Pediatric Cholestatic Liver Disease. | Hepatol Commun | 2020 |
| 33305153 | Modeling Outcomes in Children With Biliary Atresia With Native Liver After 2 Years of Age. | Hepatol Commun | 2020 |
| 32861449 | Recent developments in diagnostics and treatment of neonatal cholestasis. | Semin Pediatr Surg | 2020 |
| 32663593 | Longitudinal Outcomes in Young Patients with Alpha-1-Antitrypsin Deficiency with Native Liver Reveal that Neonatal Cholestasis is a Poor Predictor of Future Portal Hypertension. | J Pediatr | 2020 |
| 32626833 | Unraveling the Relationship Between Itching, Scratch Scales, and Biomarkers in Children With Alagille Syndrome. | Hepatol Commun | 2020 |
| 32283081 | Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity. | Mol Metab | 2020 |
| 32445649 | Reopening Schools Safely: The Case for Collaboration, Constructive Disruption of Pre-Coronavirus 2019 Expectations, and Creative Solutions. | J Pediatr | 2020 |
| 32356227 | Intestinal failure-associated liver disease (IFALD): insights into pathogenesis and advances in management. | Hepatol Int | 2020 |
| 30664273 | Identification of Polycystic Kidney Disease 1 Like 1 Gene Variants in Children With Biliary Atresia Splenic Malformation Syndrome. | Hepatology | 2019 |
| 31832574 | Up-regulation of miR-let7a-5p Leads to Decreased Expression of ABCC2 in Obstructive Cholestasis. | Hepatol Commun | 2019 |